Rydex Biotechnology Fund Class Investor (RYOIX)
NASDAQ · Mutual Fund · Delayed Price · Currency is USD
77.00
+0.66 (0.86%)
Feb 17, 2026, 8:10 AM EST

RYOIX Holdings Information

RYOIX is a mutual fund with a total of 77 individual holdings. The top holdings are AbbVie stock at 7.53%, Amgen at 4.96%, Gilead Sciences at 4.49%, Vertex Pharmaceuticals at 4.41%, and Regeneron Pharmaceuticals at 3.65%.

Total Holdings
77
Top 10 Percentage
36.83%
Asset Class
Equity
Fund Category
Health
Assets
136.15M
Forward PE Ratio
16.48

Breakdown by Sector

Top 25 Holdings

No.SymbolName WeightShares
1ABBVAbbVie Inc.7.53%35,903
2AMGNAmgen Inc.4.96%16,516
3GILDGilead Sciences, Inc.4.49%39,844
4VRTXVertex Pharmaceuticals Incorporated4.41%10,599
5REGNRegeneron Pharmaceuticals, Inc.3.65%5,152
6ALNYAlnylam Pharmaceuticals, Inc.2.90%7,947
7INSMInsmed Incorporated2.32%14,529
8NTRANatera, Inc.2.27%10,785
9AZNAstraZeneca PLC2.22%26,373
10BIIBBiogen Inc.2.09%12,936
11ONCBeOne Medicines AG2.06%7,379
12UTHRUnited Therapeutics Corporation1.85%4,137
13RPRXRoyalty Pharma plc1.83%51,524
14ILMNIllumina, Inc.1.77%14,715
15EXASExact Sciences Corporation1.77%18,983
16INCYIncyte Corporation1.66%18,317
17VTRSViatris Inc.1.61%140,709
18RVMDRevolution Medicines, Inc.1.56%21,352
19BBIOBridgeBio Pharma, Inc.1.49%21,199
20NBIXNeurocrine Biosciences, Inc.1.47%11,298
21GHGuardant Health, Inc.1.46%15,544
22BMRNBioMarin Pharmaceutical Inc.1.45%26,548
23IONSIonis Pharmaceuticals, Inc.1.43%19,693
24ARGXargenx SE1.42%1,845
25EXELExelixis, Inc.1.41%34,986
Showing 25 of 77 holdings
Subscribe to see the full list
As of Dec 31, 2025